Rising incidence of communicable disease such as HIV, influenza, tuberculosis, hepatitis due to needlestick injuries is the major factor influencing demand for needle free injection system. For instance, according to the UNAIDS organization, around 36.9 million people are living with HIV worldwide. Thus, increasing demand for needle free injection system to avoid spreading of communicable diseases.
Moreover, according to the International Diabetes Federation, in 2017, approximately 425 million adults were living with diabetes across the globe. Hence, increasing prevalence of diabetes is increasing demand of insulin needle free delivery system.
The global needle free injection system market is segmented by product, technology, type of medication, usability, side of delivery, application and end users.
Based on product type, the market is segmented into fillable needle-free injectors and prefilled needle-free injectors.
Based on technology, the needle free injection system market is segmented into vibration-based needle-free injectors, laser-powered needle-free injectors, spring-based needle-free injectors, and jet-based needle-free injectors. Jet-based needle-free injector is projected to account for the largest market share due to their advantages over the other injector systems.
Based on the usability, the needle free injection system the market is segmented into disposable needle-free injectors and reusable needle-free injectors.
On the basis of type of medication, the needle free injection system market is segmented into
Powder-based needle free injectors, Projectile/depot-based needle free injectors, Liquid-based needle free injectors.
Based on the site of delivery, the market is segmented into intradermal injectors, intramuscular injectors, and subcutaneous injectors.
Based on the application, the market is segmented into vaccine needle free delivery, pain management needle free delivery, oncology needle free delivery, insulin needle free delivery, and other applications. Insulin needle free delivery is estimated to be leading in the forecast period. Increasing prevalence of diabetic diseases across the globe is increasing the demand for insulin needle free delivery. For instance, as per, American Diabetes Association, in 2015, around 30.3 million Americans, or 9.4% of the population, were diagnosed with diabetes.
On the basis of end user, the market is segmented into research laboratories, hospitals and clinics, home care settings, pharmaceutical, and biotechnology companies and other end users. Hospitals and clinics segment is projected to grow at the highest rate due to advancement in the medication or drug delivery technology and rising geriatric population.
Geographically, the needle free injection system market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa (LAMEA).
North America is expected to hold major market share of the global needle free injection system market. This is attributed to, increasing prevalence of genetic and chronic diseases on account of growing need of the parenteral injection in various diseases. Furthermore, increasing population of obese is leading cause of diabetes. Thus, growing demand of needle free injection system is supporting the growth of the market. For instance, according to the Centres for Diseases Control and Prevention (CDC), approximately 100 million U.S population has been suffering from diabetes.
Europe is the second leading region for global needle free injection system market. This is attributed to increasing awareness about the health and advancement in needle free injection system. Rising demand of needle free injection system for vaccination is supporting the growth of market.
Asia Pacific is expected to fastest growing market during forecast period. This is attributed to rising incidence of diabetes in India and China. Needle free injection system widely used for injecting insulin, thus, increasing prevalence of diabetes in this region is boosting demand of the market.
On the other hand, the Middle East & Africa holds the least share in the market due to the limited availability of funds, poor healthcare infrastructure, and low spending power in Africa region. However, the region is expecting a sound growth due to many untapped opportunities in this region.
Some of the key players in the global needle free injection systems market include Endo International plc, Antares Pharma, Inc., PenJet Corporation, Bioject Medical Technologies Inc., Medical International Technology, Inc., PharmaJet, National Medical Products Inc., Valeritas, Inc., INJEX Pharma AG, European Pharma Group and Crossject SA.
Needle Free Injection Systems Market Segmentation
By Type of Medication
By Site of Delivery
By End User